Correction: Reynard, O.; et al. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses 2015, 7, 6233‒6240.

The Viruses Editorial Office wishes to notify its readers of corrections in [1].[...].

The Viruses Editorial Office wishes to notify its readers of corrections in [1].

The authors refer to [2], writing that the experiments were done using 126 mM/kg/day for mouse treatment without side effects. The correct dose used in [2] was 126 µmol/kg/day.

On page 6235, the last sentence of the first paragraph should read: “These data are in line with published reports on the absence of significant toxicity caused by the inhibitor at the concentration below 75–100 M in Madin-Darby canine kidney cells (MDCK), human hepato cellular carcinoma cells (HUH), HepG2 cells or ex vivo in human peripheral blood monocytes [13], as well as in a mouse model where NHC was provided up to 126 µmol per kilogram of body weight during five consecutive days without any measurable side effects [13]”.

The original Figure 3 was in French and has been replaced by the following:

The manuscript will be updated and the original will remain available on the article webpage. The authors would like to apologize for any inconvenience caused.